HY-C

N/A

Report date: 2025/01/08 14:53:49

Base Information

Drug NameHY-C
Drug Alias NameHY-C
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsEndomyocardial FibrosisPulmonary FibrosisPancreatic Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJuventas Cell Therapy Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEndomyocardial FibrosisPulmonary FibrosisPancreatic Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A